Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMCL.2007.09.100PMID 17998161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Progress toward a practical BACE-1 inhibitor.

  2007cited by this paper
• Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors

  2007cited by this paper
• Fragments, network biology and designing multiple ligands.

  2007cited by this paper
• Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives.

  2007cited by this paper
• AClAP, Autonomous hierarchical agglomerative Cluster Analysis based protocol to partition conformational datasets

  2006cited by this paper
• A Comparative Study on the Application of Hierarchical-Agglomerative Clustering Approaches to Organize Outputs of Reiterated Docking Runs

  2006cited by this paper
• Development and validation of a modular, extensible docking program: DOCK 5

  2006cited by this paper
• Development of BACE1 inhibitors for Alzheimer's disease.

  2006cited by this paper
• Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years

  2005cited by this paper
• Designed multiple ligands. An emerging drug discovery paradigm.

  2005cited by this paper
• The potential for BACE1 inhibitors in the treatment of Alzheimer's disease.

  2004cited by this paper
• The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development

  2003cited by this paper
• 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy.

  2003cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Beta-secretase as a target for the treatment of Alzheimer's disease.

  2002cited by this paper
• β‐secretase as a target for the treatment of Alzheimer's disease

  2002cited by this paper
• A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation.

  2001cited by this paper
• Translating cell biology into therapeutic advances in Alzheimer's disease

  1999cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper
• Normal and abnormal biology of the beta-amyloid precursor protein.

  1994cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• Synergistic effects of doxorubicin and coumarin on colorectal cancer cell proliferation and EMT modulation: in silico and in vitro study

  2025cites this paper
• COMPARATIVE MOLECULAR DOCKING STUDIES OF 7-HYDROXY COUMARIN DERIVATIVES

  2025cites this paper
• The Evolution of AChE Inhibitors in Alzheimer's Disease: From Single‐Target to Multi‐Target Ligands

  2025cites this paper
• Microwave-Assisted Synthesis of Heterocyclic Scaffolds

  2024cites this paper
• 3-Acetyl coumarin alleviate neuroinflammatory responses and oxidative stress in aluminum chloride-induced Alzheimer’s disease rat model

  2024influential citation
• Biological evaluation of trans-2,3-dihydrofuro[3,2-c]coumarins as potential cathepsin inhibitors and anticancer agents

  2024cites this paper
• Sc(OTf)3‐catalyzed tandem (3+3)‐annulation/lactonization of cyclopropanes with salicylaldehyde nitrones to access polycyclic 1,2‐oxazines

  2024cites this paper
• Design, Synthesis and Molecular Docking Studies of Tailored Coumarin and Chromone Derivatives for Use as Anti-Alzheimer Agents

  2024cites this paper
• Recent advances in the natural product analogues for the treatment of neurodegenerative diseases.

  2024cites this paper
• Synthesis and evaluation of the anti-TB activity of novel 7-(2-(4-substituted-phenyl)-4,5-diphenyl-1H-imidazol-1-yl)-4-methyl-2H-chromen-2-one derivatives and their DFT studies for NLO application

  2024cites this paper
• Pesticide Engineering from Natural Vanillin: Recent Advances and a Perspective

  2024cites this paper
• Multi-target directed ligands inspired natural products as an effective approach for the treatment of complex chronic health disorders.

  2024cites this paper
• Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach.

  2023cites this paper
• Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities.

  2023cites this paper
• Coumarin Derivatives: Mechanistic Insights and Promising Applications as Potential Alzheimer's Disease (AD) Therapeutic Agents

  2023cites this paper
• Pharmacophore based virtual screening of cholinesterase inhibitors: search of new potential drug candidates as antialzheimer agents

  2022cites this paper
• Recent advances in the development of nitrogen-containing heterocyclic Anti-Alzheimer's agents.

  2022cites this paper
• Ameliorating potential of curcumin and its analogue in central nervous system disorders and related conditions: A review of molecular pathways

  2022cites this paper
• Recent literature review on Coumarin hybrids as potential anti-cancer agents.

  2022cites this paper
• Acetylcoumarin in cyclic and heterocyclic-containing coumarins: Synthesis and biological applications

  2022cites this paper
• Synthesis of New 3-Arylcoumarins Bearing N-Benzyl Triazole Moiety: Dual Lipoxygenase and Butyrylcholinesterase Inhibitors With Anti-Amyloid Aggregation and Neuroprotective Properties Against Alzheimer’s Disease

  2022cites this paper
• A efficient, metal-free and sustainable synthesis, C-S linked by simple C-H thiocyanation of 4-aminocoumarin or 4-(N-aryl)aminocoumarin derivativess

  2022cites this paper
• Multitarget drugs as potential therapeutic agents for alzheimer’s disease. A new family of 5-substituted indazole derivatives as cholinergic and BACE1 inhibitors

  2022cites this paper
• Coumarin Derivatives Containing Sulfonamide and Dithioacetal Moieties: Design, Synthesis, Antiviral Activity, and Mechanism.

  2022cites this paper
• Anti-Alzheimer's disease potential of traditional chinese medicinal herbs as inhibitors of BACE1 and AChE enzymes.

  2022cites this paper
• Mechanistic insights and docking studies of phytomolecules as potential candidates in the management of cancer.

  2022cites this paper
• Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo

  2022cites this paper
• HPLC–DAD characterization of phenolic profile and in vitro antioxidant, anticholinesterase, and antidiabetic activities of five mushroom species from Turkey

  2021cites this paper
• Design, solvent-free synthesis and antibacterial activity evaluation of new coumarin sulfonamides

  2021cites this paper
• Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells

  2021cites this paper
• Promising tacrine/huperzine A‐based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget

  2021cites this paper
• Efficient synthesis of chromeno[4,3-b]pyrano[3,4-e]pyridine-6,8-dione derivatives via multicomponent one-pot reaction under mild reaction conditions in water

  2021cites this paper
• Design, synthesis, structural analysis and quantum chemical insight into the molecular structure of coumarin derivatives

  2021cites this paper
• Fe3O4@SiO2@(CH2)3-urea-quinoline sulfonic acid chloride: A novel catalyst for the synthesis of coumarin containing 1,4 dihydropyridines

  2021cites this paper
• Multi-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity

  2021cites this paper
• Coumarin linked heterocyclic hybrids: A promising approach to develop multi target drugs for Alzheimer's disease

  2021cites this paper
• Potential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Disease

  2021cites this paper
• Multi-target inhibition ability of neohesperidin dictates its neuroprotective activity: Implication in Alzheimer's disease therapeutics.

  2021cites this paper
• Alzheimer's Disease and β-Secretase Inhibition: An Update With a Focus on Computer-Aided Inhibitor Design.

  2021cites this paper
• Synthesis, characterization, structural exploration and quantum chemical calculations of (E)-8-(1-((4-aminobenzyl)imino)ethyl)-7-hydroxy-4-methyl-coumarin

  2020cites this paper
• A review: Biologically active 3,4-heterocycle-fused coumarins.

  2020cites this paper
• Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis

  2020cites this paper
• KF/CP Nanoparticles Promoted Three Component Green Synthesis of Chromene Derivatives

  2020cites this paper
• Computer-Aided Drug Design Applied to Secondary Metabolites as Anticancer Agents.

  2020cites this paper
• ZnCl2 catalyzed new coumarinyl-chalcones as cytotoxic agents

  2020cites this paper
• Design, synthesis and biological activity evaluation of novel carbazole-benzylpiperidine hybrids as potential anti Alzheimer agents

  2020cites this paper
• RECENT STRATEGIES FOR EFFICIENT SYNTHESIS AND BIOLOGICAL ACTIVITIES OF COUMARIN-CHALCONE DERIVATIVES

  2020cites this paper
• Coumarin sulfonamide derivatives: An emerging class of therapeutic agents

  2020cites this paper
• Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.

  2020cites this paper
• Discovery of new potential triplet acting inhibitor for Alzheimer’s disease via X-ray crystallography, molecular docking and molecular dynamics

  2020cites this paper
• Zirconium(IV) Oxychloride: A Simple and Efficient Catalyst for the Synthesis of Chromen-2-one Derivatives

  2020cites this paper
• New naphthalene derivative for cost-effective AChE inhibitors for Alzheimer's treatment: In silico identification, in vitro and in vivo validation

  2020cites this paper
• Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease.

  2020cites this paper
• EVALUATION OF ANTIOXIDANT AND CHOLINESTERASE INHIBITORY ACTIVITIES OF SOME MEDICINAL PLANTS

  2019cites this paper
• Multitarget therapeutic strategies for Alzheimer’s disease

  2019cites this paper
• Phytochemical contents, antioxidant effects, and inhibitory activities of key enzymes associated with Alzheimer's disease, ulcer, and skin disorders of Sideritis albiflora and Sideritis leptoclada.

  2019cites this paper
• Neurobehavioral investigation and acetylcholinesterase inhibitory activity study for some new coumarin derivatives.

  2019cites this paper
• Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease

  2019cites this paper
• Coumarin derivatives as acetyl- and butyrylcholinestrase inhibitors: An in vitro, molecular docking, and molecular dynamics simulations study

  2019cites this paper
• Probing the interaction of a coumarin-di(2-picolyl)amine hybrid drug-like molecular entity with human serum albumin: Multiple spectroscopic and molecular modeling techniques.

  2019cites this paper
• 3‐Aryl Coumarin Derivatives Bearing Aminoalkoxy Moiety as Multi‐Target‐Directed Ligands against Alzheimer's Disease

  2019cites this paper
• Rationally designed small molecules targeting toxic CAG repeat RNA that causes Huntington's disease (HD) and spinocerebellar ataxia (SCAs).

  2019cites this paper
• Natural product coumarins: biological and pharmacological perspectives

  2019cites this paper
• Green Synthesis of Spiropyranone 3-Aryl-4-Methylcoumarin Derivatives using Carbonyldiimidazole

  2019cites this paper
• Synthesis of coumarin based Knoevenagel-Ugi adducts by a sequential one pot five-component reaction and their biological evaluation as anti-bacterial agents

  2019cites this paper
• Identifying natural compounds as multi-target-directed ligands against Alzheimer’s disease: an in silico approach

  2019cites this paper
• Spectroscopic Evaluation of Novel TacrineCoumarin Hybrids as HSA-Interacting Agents

  2019cites this paper
• Synthesis, molecular properties and comparative docking and QSAR of new 2-(7-hydroxy-2-oxo-2H-chromen-4-yl)acetic acid derivatives as possible anticancer agents.

  2019cites this paper
• Identify Compounds' Target Against Alzheimer's Disease Based on In-Silico Approach.

  2019cites this paper
• Design, Synthesis and Antiviral Activity of Coumarin Derivatives Containing Dithioacetal Structures.

  2019cites this paper
• Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer’s Disease

  2018cites this paper
• Network Pharmacology-Based Approach to Investigate the Mechanisms of Hedyotis diffusa Willd. in the Treatment of Gastric Cancer

  2018cites this paper
• Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease

  2018cites this paper
• Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design

  2018cites this paper
• Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.

  2018cites this paper
• Novel 3-phenylcoumarin-lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease.

  2018cites this paper
• Synthesis and Characterization of Novel Phthalimide-pyrano[3,2-c ]chromene and Phthalimide-pyrano-2-one Hybrids

  2018cites this paper
• Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design

  2018influential citation
• Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors.

  2018cites this paper
• Development of coumarin–benzofuran hybrids as versatile multitargeted compounds for the treatment of Alzheimer’s Disease

  2018cites this paper
• Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds

  2018influential citation
• Characterization of the interactions between coumarin-derivatives and acetylcholinesterase: Examination by NMR and docking simulations

  2018cites this paper
• New tacrine–acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease

  2018cites this paper
• Synthesis of Novel 1,2,4-Triazolyl Coumarin Derivatives as Potential Anticancer Agents

  2018cites this paper
• Coumarin-Based Molecules as Suitable Models for Developing New Neuroprotective Agents Through Structural Modification

  2018cites this paper
• Water‐Mediated One‐Pot Three‐Component Reaction to Bifunctionalized Thiadiazoloquinazolinone‐coumarin Hybrids: A Green Approach

  2018cites this paper
• Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents

  2018cites this paper
• Multifactorial Hypothesis and Multi-Targets for Alzheimer’s Disease

  2018cites this paper
• Synthesis and antioxidant activity of a new 4-aminocoumarin derivative

  2018cites this paper
• BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease.

  2017cites this paper
• Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study

  2017cites this paper
• Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-β aggregation for the treatment of Alzheimer's disease.

  2017cites this paper
• Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation.

  2017cites this paper
• Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action

  2017cites this paper
• UNIVERSITY OF PRISTINA-FACULTY OF SCIENCES KOSOVSKA MITROVICA-REPUBLIC OF SERBIA

  2017cites this paper
• Acetamide Derivatives of Chromen‐2‐ones as Potent Cholinesterase Inhibitors

  2017cites this paper
• CADD Modeling of Multi-Target Drugs Against Alzheimer's Disease.

  2017cites this paper
• Facile and Chemically Sustainable Catalyst‐Free Synthesis of Diverse 2‐Aryl‐4‐Alkyl/Aryl‐Pyrano[3,2‐c]chromen‐5(4H)‐Ones by One‐Pot Multicomponent Reactions at Room Temperature

  2017cites this paper
• Multi-targeting Strategies for Alzheimer's Disease Therapeutics: Pros and Cons.

  2017cites this paper
• Identification of Novel BACE1 Inhibitors by Combination of Pharmacophore Modeling, Structure-Based Design and In Vitro Assay.

  2016cites this paper